Hims & Hers Health Inc. buy BiotechBee
Start price
11.05.25
/
70%
€47.89
Target price
31.08.27
€100.00
Performance (%)
-10.00%
End price
29.06.25
€43.10
Summary
This prediction ended on 29.06.25 with a price of €43.10. The prediction for Hims & Hers Health Inc. disappointed with a performance of -10.00%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Hims & Hers Health Inc. | -5.237% | -5.237% | -38.658% |
| iShares Core DAX® | 1,00 % | 4,83 % | 8,15 % |
| iShares Nasdaq 100 | 2,70 % | -1,72 % | 26,92 % |
| iShares Nikkei 225® | 3,52 % | -3,51 % | 48,06 % |
| iShares S&P 500 | 1,77 % | 1,27 % | 23,58 % |
According to BiotechBee what are the pros and cons of Hims & Hers Health Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Buy mit Kursziel 100,0
In the thread Trading Hims & Hers Health Inc.
Buy beendet

